The intricacies of neurotrophic factor therapy for retinal ganglion cell rescue in glaucoma: a case for gene therapy
Regeneration of damaged retinal ganglion cells (RGC) and their axons is an important aspect of reversing vision loss in glaucoma patients. While current therapies can effectively lower intraocular pressure, they do not provide extrinsic support to RGCs to actively aid in their protection and regener...
Main Authors: | Marianna Foldvari, Ding Wen Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Neural Regeneration Research |
Subjects: | |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2016;volume=11;issue=6;spage=875;epage=877;aulast=Foldvari |
Similar Items
-
Retinal ganglion cell loss and gliosis in the retinofugal projection following intravitreal exposure to amyloid-beta
by: E.S. Simons, et al.
Published: (2021-01-01) -
Changes in NMDA receptor contribution to synaptic transmission in the brain in a rat model of glaucoma
by: A.L. Georgiou, et al.
Published: (2010-09-01) -
Target-Derived Neurotrophic Factor Deprivation Puts Retinal Ganglion Cells on Death Row: Cold Hard Evidence and Caveats
by: Marie Claes, et al.
Published: (2019-09-01) -
Age Related Response of Neonatal Rat Retinal Ganglion Cells to Reduced TrkB Signaling in vitro and in vivo
by: Jamie Beros, et al.
Published: (2021-06-01) -
Brain derived neurotrophic factor keeps pattern electroretinogram from dropping after superior colliculus lesion in mice
by: Bin-Bin Yang, et al.
Published: (2016-03-01)